LDS/Medical Tests/Bacterial Vaginosis Pathogens by Molecular Method

Bacterial Vaginosis Pathogens by Molecular Method

Bacterial Vaginosis (BV) is a clinical syndrome characterized by itching, burning, and abnormal vaginal discharge accompanied with a rise in pH and an amine (fishy) smell. While the cause of Bacterial Vaginosis is unknown, the condition reflects a shift in vaginal flora from predominately lactobacillus species to bacteria such as: Gardnerella vaginalis (GV), Atopobium vaginae (AV), anaerobic gram-negative to gram-variable rods belonging to the genera Megasphaera, Prevotella, and Mobiluncus and a variety of other bacteria. It has not been proven that any of these organisms alone is able to cause BV, but their numbers are increased in confirmed BV. Along with a change in ratio of the vaginal flora, clue cells are often present in BV. Clue cells are vaginal squamous epithelial cells that are covered with bacteria (bacilli and coccobacilli) that destroy or blur the visibility of the cell margins

Risk factors for BV include: having more than one sexual partner, having changed partners in the previous 30 days, having a female sexual partner, and douching. Bacterial vaginosis is associated with upper genital tract infections, pelvic inflammatory disease, and adverse pregnancy outcomes. An increased risk of sexually transmitted infections is also associated with BV. Although the etiology, pathology, microbiology and transmission of BV is poorly understood, there is evidence that BV has many of the characteristics of a sexually transmitted infection and can be sexually transmitted. However, treatment of sexual partners has not been shown to lower BV recurrence rates and BV is not considered a STD.

The diagnosis of BV is usually made with Amsel’s criteria, a clinical diagnostic practice performed at bedside, or by the gold-standard Nugent score (NS). Amsel’s criteria (vaginal discharge, positive whiff test, pH >4.5 and presence of clue cells) is a subjective method. At least three of these are necessary for BV diagnosis. PCR assays that directly detect and semi-quantitatively gives a ratio between BV normal and abnormal flora are increasingly recommended tests for diagnosis of BV. Some tests might include yeast species also associated with yeast vaginitis and Trichomonas vaginalis, the most common cause of vulvovaginitis. However, since the prevalence of BV is higher than the latter, testing for BV using PCR assay first is highly recommended.

  • As an aid in diagnosis of bacterial vaginosis
  • Therapy and disease management
Positive results indicate bacterial vaginosis. Intermediate results depend on the time of collection and most of the time might progress to bacterial vaginosis, therefore, in conjunction with clinical picture, intermediate results can be considered as positive.

Negative for bacterial vaginosis

Multiplex Real-time PCR, Transcription Mediated Expression (TMA) assay that detects L. bacilli and most common facultative pathogens.

Vaginal swab, eSwab, APTIMA swab

Stability

  • Ambient: 1-3 days
  • Refrigerated: 7 days
Yeast species by molecular method or yeast culture, Trichomonas vaginalis, Chlamydia trachomatis and Neisseria gonorrhoeae by molecular method, HPV, PAP smear.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login